Gengos Andrew 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Gengos Andrew（CIK 1563623）在 2 家公司共报告 9 笔 SEC Form 4 内部人交易（最近一笔 2026-05-05）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-05-05 | Terns Pharmaceuticals, Inc. (TERN) | Chief Financial Officer | 卖出 | 40,503 | $2.1M |
| 2026-05-05 | Terns Pharmaceuticals, Inc. (TERN) | Chief Financial Officer | 卖出 | 68,750 | $3.6M |
| 2026-01-16 | Terns Pharmaceuticals, Inc. (TERN) | Chief Financial Officer | 买入 | 68,750 | $0 |
| 2025-10-10 | Turn Therapeutics Inc. (TTRX) | 董事 | 买入 | 10,000 | $0 |
| 2025-06-30 | Terns Pharmaceuticals, Inc. (TERN) | Chief Financial Officer | 买入 | 5,000 | $19,650 |
| 2025-06-30 | Terns Pharmaceuticals, Inc. (TERN) | Chief Financial Officer | 买入 | 5,000 | $19,650 |
| 2025-06-16 | Terns Pharmaceuticals, Inc. (TERN) | Chief Financial Officer | 买入 | 5,000 | $18,750 |
| 2025-06-16 | Terns Pharmaceuticals, Inc. (TERN) | Chief Financial Officer | 买入 | 5,000 | $18,600 |
| 2025-06-16 | Terns Pharmaceuticals, Inc. (TERN) | Chief Financial Officer | 买入 | 5,000 | $19,750 |
来源：SEC Form 4 申报文件 · 截至 2026-05-05